Martha’s Rule: No Sanction for Doctor
- Prof. Richard Thompson, a senior doctor previously found guilty of misconduct related to the death of 13-year-old martha Mills, will not face sanctions.
- thompson was the consultant on duty at King’s College Hospital on Aug.
- The tribunal had determined that Thompson failed to escalate Martha’s treatment to intensive care or conduct a necessary in-person assessment after being alerted to a rash.
Doctor richard thompson avoids sanctions despite a misconduct finding in the tragic case of 13-year-old Martha Mills, whose death spurred the creation of primary_keyword: “Martha’s Rule.” A disciplinary tribunal cited “exceptional circumstances” when concluding Thompson’s career, noting the severity of the single lapse in judgment. This decision, however, has ignited debates on patient safety, the critical role of second opinions, and the impact on public trust. The case involves the secondary_keyword: “sepsis.” Though the General Medical Council pushed for suspension, the tribunal’s choice to forgo sanctions has spurred conversations. News directory 3 follows this closely. Will Martha’s Rule’s impact on patient care in England continue to grow? Discover what’s next…
Doctor Faces No Sanction in Martha Mills Case Despite Misconduct Finding
Updated June 11, 2025
Prof. Richard Thompson, a senior doctor previously found guilty of misconduct related to the death of 13-year-old martha Mills, will not face sanctions. The disciplinary tribunal cited “exceptional circumstances” in its Wednesday decision, noting the incident as a “single lapse of judgment in an or else exemplary career.” The case has drawn attention to patient safety and the importance of second opinions.
thompson was the consultant on duty at King’s College Hospital on Aug. 29, 2021, two days before Martha’s death from sepsis. Martha’s death led to the creation of Martha’s Rule, now implemented in numerous English hospitals, granting patients the right to seek a second medical opinion. This initiative aims to improve patient care and outcomes.
The tribunal had determined that Thompson failed to escalate Martha’s treatment to intensive care or conduct a necessary in-person assessment after being alerted to a rash. A 2022 coroner’s inquest suggested Martha likely would have survived had she been moved to intensive care sooner, a request her parents had made.
Robin Ince, who chaired the panel at the Medical Practitioners Tribunal Service, stated that the decision to forgo sanctions considered that Thompson neither caused nor contributed to Martha’s death. Ince added that the misconduct finding itself would serve as a “meaningful stigma” and a “continuing embarrassment” for thompson, sending a clear message to the medical profession about clinical judgment.
“King’s College hospital’s own report into Martha’s death made it clear that the high-status consultants on her ward had a poor relationship with paediatric intensive care, which helps to explain why Martha wasn’t referred there when, as every expert has agreed, she should have been. We will never understand why experienced doctors,with elevated reputations,took such a big risk with her life.”
Merope Mills and Paul Laity, Martha’s parents
Christopher Rose, representing the General Medical Council, had advocated for Thompson’s suspension, arguing that inaction would undermine the tribunal’s findings and public trust. Tho, Ince countered that a suspension would deprive the public of Thompson’s valuable expertise as a hepatologist, deeming the decision to take no action as not jeopardizing public protection.
Martha Mills sustained a pancreatic injury in a bicycle accident while on holiday in Wales. She was transferred to intensive care at King’s College hospital on Aug. 30, 2021, already suffering from septic shock.
In March, the Commons health and social care committee learned that Martha’s Rule had been invoked over 2,000 times, leading to improved care for more than 300 patients and escalation to intensive care for over 100.
What’s next
the implementation and impact of Martha’s Rule will continue to be monitored across hospitals in England, with ongoing evaluation of its effectiveness in improving patient outcomes and promoting patient safety.